Novo Nordisk internal systems breached; pseudonymized clinical-trial patient data copied out

Novo Nordisk said it identified unauthorized access to a limited number of internal IT systems and found certain non-public data, including personal data, was copied externally; some systems were taken offline while core operations continued ^[1]. The company said affected clinical-trial patient data is pseudonymized and not linked to names or other direct identifiers; according to BleepingComputer, it also warned healthcare professionals to watch for suspicious messages and calls ^[1][2]. Novo Nordisk recommends trial patients remain vigilant and report anything unusual they believe could be linked to the incident ^[1].

Industries mainly affected: Healthcare

1. Clinical-trial patients should remain vigilant and report anything unusual to Novo Nordisk ^[1].
2. Healthcare professionals should beware of unexpected messages or calls impersonating colleagues .